Skip to main content

From the Experts

Clinical Editor's Corner
02/01/2026
Morton J. Kern, MD, MSCAI, FACC, FAHA; Samuel M. Butman, MD; Kirk N. Garratt, MD, MSc; Neal S. Kleiman, MD; J. Jeffrey Marshall, MD; Stephen R. Ramee, MD; Kenneth Rosenfield, MD, MHCDS; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Dr. Morton Kern and his expert colleagues discuss communication and how it may be received by team members in the cath lab.
Dr. Morton Kern and his expert colleagues discuss communication and how it may be received by team members in the cath lab.
Dr. Morton Kern and his expert...
02/01/2026
Cath Lab Digest
Clinical Trial Update
01/30/2026
Donald E. Cutlip, MD
SELUTION4ISR is a prospective, international, randomized, single-blind clinical trial evaluating a sirolimus-eluting balloon for the treatment of coronary in-stent restenosis in arteries with up to two layers of bare-metal or drug-eluting...
SELUTION4ISR is a prospective, international, randomized, single-blind clinical trial evaluating a sirolimus-eluting balloon for the treatment of coronary in-stent restenosis in arteries with up to two layers of bare-metal or drug-eluting...
SELUTION4ISR is a prospective,...
01/30/2026
Cath Lab Digest
Clinical Editor's Corner
01/23/2026
Morton J. Kern, MD, MSCAI, FACC, FAHA
"Engage your passion and begin the questioning of conventional wisdom," says Dr. Kern. "In your research, accept setbacks and obstacles. Do not be afraid to fail."
"Engage your passion and begin the questioning of conventional wisdom," says Dr. Kern. "In your research, accept setbacks and obstacles. Do not be afraid to fail."
"Engage your passion and begin...
01/23/2026
Cath Lab Digest
Structural Heart Disease
12/16/2025
Kayla Wong, BS; Jennifer Nguyen, BS, CCRC; Evan Walser-Kuntz, MS; Sara Olson, RN, CCRC; Le Nguyen, BS; Tremayne Ansani, BS; Andrew Willett, BS; Mario Gössl MD, PhD, MHA
This retrospective single-center study characterizes mitral regurgitation progression in 277 patients who underwent TAVR over a five-year follow-up period.
This retrospective single-center study characterizes mitral regurgitation progression in 277 patients who underwent TAVR over a five-year follow-up period.
This retrospective single-center...
12/16/2025
Cath Lab Digest
RDN & REIMBURSEMENT
12/15/2025
Taisei J. Kobayashi, MD
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and...
12/15/2025
Cath Lab Digest
Program Spotlight
12/09/2025
Amir Lotfi, MD; Andrew M. Goldsweig, MD
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture,...
12/09/2025
Cath Lab Digest
Clinical Editor's Corner
12/05/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA
On my last cath day, I was standing next to a freshly-minted first-year cardiology trainee. It was a bittersweet moment — a cliché, but true. How many fellows have I worked with? How many unusual patients and novel findings, and how many...
On my last cath day, I was standing next to a freshly-minted first-year cardiology trainee. It was a bittersweet moment — a cliché, but true. How many fellows have I worked with? How many unusual patients and novel findings, and how many...
On my last cath day, I was...
12/05/2025
Cath Lab Digest
Hemostasis
12/05/2025
Gautam Kumar, MD, FSCAI; Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS
As transradial access continues to dominate the interventional cardiology landscape, attention has increasingly shifted to optimizing post-procedural management, particularly radial artery closure.
As transradial access continues to dominate the interventional cardiology landscape, attention has increasingly shifted to optimizing post-procedural management, particularly radial artery closure.
As transradial access continues...
12/05/2025
Cath Lab Digest
Ask the Experts
11/01/2025
Manit Sabharwal ; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton...
11/01/2025
Cath Lab Digest
Clinical Editor's Corner
10/31/2025
Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Cardiogenic shock is clearly different than bacteremic, neurogenic, toxic, and traumatic (hypovolemic) shock. Significant research progress has been made just in arriving at a common language for shock, through the Society for Cardiovascular...
Cardiogenic shock is clearly different than bacteremic, neurogenic, toxic, and traumatic (hypovolemic) shock. Significant research progress has been made just in arriving at a common language for shock, through the Society for Cardiovascular...
Cardiogenic shock is clearly...
10/31/2025
Cath Lab Digest